Exelixis (NasdaqGS:EXEL) 2025 Earnings Call Presentation
Exelixis(US:EXEL)2025-12-10 18:00DECEMBER 10, 2025 Exelixis 2025 R&D Day: Building Next-generation Oncology Franchises Agenda Presenters: Susan Hubbard, EVP, Public Affairs & IR Michael M. Morrissey, Ph.D., President & CEO Dana T. Aftab, Ph.D., EVP, Research & Development PJ Haley, EVP, Commercial 2 • Strategic Overview • RCC Franchise Panel with Guest Speaker: Dr. Toni Choueiri, Dana-Farber, Harvard • CRC Franchise Panel with Guest Speaker: Dr. Anwar Saeed, UPMC Hillman • Neuroendocrine Franchise Panel with Guest Speaker: Dr. Jennifer Cha ...